Mutation Analysis of Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer for Selection of Patients Eligible for Tyrosine Kinase Inhibitor Therapy Cover

.blurhash-client-img { display: none !important; }

Mutation Analysis of Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer for Selection of Patients Eligible for Tyrosine Kinase Inhibitor Therapy

Journal of Cancer and Allied Specialties

Volume 10 (2024): Issue 1 (January 2024)

By: Zeeshan Ansar, Asghar Nasir and Tariq Moatter

Open Access

|Jan 2024

Authors

Zeeshan Ansar

Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan

Asghar Nasir

Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan

Tariq Moatter

tariq.moatter@aku.edu

Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan

DOI: https://doi.org/10.37029/jcas.v10i1.569 | Journal eISSN: 2411-989X

Journal RSS Feed

Language: English

Page range: 1 - 9

Submitted on: Aug 3, 2023

Accepted on: Dec 8, 2023

Published on: Jan 23, 2024

Published by: Shakuat Khanum Memorial Cancer Hospital and Research Centre

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

Epidermal growth factor receptor,

mutation analysis,

non-small-cell lung cancer,

tyrosine kinase inhibitors

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Haematology, oncology,

Pediatrics and juvenile medicine,

Paediatric haematology and oncology,

© 2024 Zeeshan Ansar, Asghar Nasir, Tariq Moatter, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License.

Previous article Volume 10 (2024): Issue 1 (January 2024)Next article